Denis Chem Lab Ltd — Others, 30-05-2025: Corp Action

DENIS CHEM LAB LIMITED

MANUFACTURERS OF PARENTERAL PRODUCTS

[CIN: L24230GJ1980PLC003843]

ADDRESS: 401 – ABHISHREE, OPP. OM TOWER, SATELLITE ROAD, AHMEDABAD – 380 015 GUJARAT, INDIA TEL.: +91 (79) 26925716, 26925719 FAX: +91 (79) 26925710 Email:denischem401@gmail.com

REGD OFFICE & FACTORY: BLOCK NO. 457, VILLAGE: CHHATRAL, TAL: KALOL (N.G.) DIST: GANDHINAGAR – 382 729 GUJARAT,

TEL: +91 (2764) 233596, 233613 FAX: +91 (2764) 233896 WEB: www.denischemlab.com

30th May, 2025

BSE Limited

Phiroze Jeejeebhoy Towers,

Dalal Street, Fort,

Mumbai – 400001

Company Code No. 537536

Dear Sir,

Sub: - Outcome of Board Meeting

- Submission of Audited Financial Results for the financial year ended on 31st March, 2025

We refer to our letter dated 19th May, 2025 informing the date of Meeting of the Board of Directors of the

Company.

Please note that the Board of Directors of the Company, in their meeting held today i.e. on 30th May,

2025, interalia, has:

1. Approved the Standalone Audited Financial Statements of the Company for Quarter and Financial Year

ended on 31st March, 2025 as recommended by the Audit Committee.

2. Recommended a Final dividend of Rs. 1.50 per Equity Share of Rs.10/- each for the financial year

2024-25 ended on 31st March, 2025, subject to approval of shareholders at the ensuing Annual General

Meeting.

Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we enclose the following:

1. Statement of Audited Financial Results for the financial year ended on 31st March, 2025- Integrated

Filing (Financial).

2. Auditors’ Report on the Audited Financial Results for the financial year ended on 31st March, 2025.

3. Declaration to the effect that there is Unmodified Opinion with respect to Audited Financial Results for

the financial year ended on 31st March, 2025.

The Meeting of Board of Directors was commenced at 10:00 a.m. and concluded at 1:45 p.m.

Thanking you,

Yours faithfully,

for DENIS CHEM LAB LIMITED

HIMANSHU C. PATEL

MANAGING DIRECTOR

(DIN: 00087114)

Encl: As above

----------------Page (0) Break----------------

SHAH & SHAH ASSOCIATES

CHARTERED ACCOUNTANTS

702, ANIKET, Nr. MUNICIPAL MARKET,

e.G. ROAD, NAVRANGPURA, AHMEDABAD -380 009.

PHONE: 26465433

FAX: 079 -26406983 Email: ca@shahandshah.cO.in

INDEPENDENT AUDITOR'S REPORT ON FINANCIAL RESULTS OF DENIS CHEM LAB

LIMITED PURSUANT TO REGULATIONS 33 OF SEBI (LISTING OBLIGATION AND

DISCLOSURE REQUIREMENT) REGULATIONS,201S, AS AMENDED.

TO THE BOARD OF DIRECTORS OF DENIS CHEM LAB LIMITED

Report on the audit of the Financial Results

Opinion

We have audited the accompanying statement of quarterly and year to date financial results

of DENIS CHEM LAB LIMITED ("the Company") for the quarter and year ended on 31st

March 2025 (the "Statement") being submitted by the Company pursuant to the requirement

of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,

2015, as amended (the "Listing Regulations").

In our opinion and to the best of our information and according to the explanations given to

us, the aforesaid financial results:

i. are presented in accordance with the requirements of Regulation 33 of the Listing

Regulations in this regard; and

ii. gives a true and fair view in conformity with the recognition and measurement

principles laid down in the applicable accounting standards and other accounting

principles generally accepted in India, of the net profit and other comprehensive

income and other financial information for the quarter and year ended 31st March

2025.

Basis for Opinion

We conducted our audit in accordance with the Standards on Auditing ("SAs") specified under

Section 143(10) of the Companies Act, 2013 ("the Act"). Our responsibilities under those SAs

are further described in the Auditor's Responsibilities for the Audit of the Financial Results

section of our report. We are independent of the Company, in accordance with the Code of

Ethics issued by the Institute of Chartered Accountants of India together with the ethical

requirements that are relevant to our audit of the financial statements under the provisions

of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in

accordance with these requirements and the Code of Ethics. We believe that the audit

evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Management's Responsibilities for the Financial Results

These financial results have been prepared on the basis of the Financial Statements. The

Board of Directors of the Company are responsible for the preparation and presentation of the

Statement that give a true and fair view of the net profit and other comprehensive income

and other financial information in accordance with the applicable Accounting Standard

prescribed under Section 133 of the Act read with relevant rules issued thereunder and other

accounting principles generally accepted in India and in compliance with Regulation 33 of the

Listing Regulations. This responsibility also includes maintenance of adequate accounting

records in accordance with the provisions of the Act for safeguarding of the assets of the

Company and for preventing and detecting frauds and other irregularities; selection and

application of appropriate accounting policies; making judgments and estimates that are

reasonable and prudent; and design, implementation and maintenance of adequate internal

financial controls that were operating effectively for ensuring the accuracy and completeness

of the accounting records, relevant to the preparation and presentation of the financial results

that give a true and fair and are free from material misstatement, whether due to fraud

or error.

----------------Page (1) Break----------------

SHAH & SHAH ASSOCIATES

CHARTERED ACCOUNTANTS

702, ANIKET, Nr. MUNICIPAL MARKET,

e.G. ROAD, NAVRANGPURA, AHMEDABAD -380 009.

PHONE: 26465433 FAX: 079 -26406983

Email: ca@shahandshah.co.ln

In preparing the financial results, the Board of Directors are responsible for assessing the

Company's ability to continue as a going concern, disclosing, as applicable, matters related to

going concern and using the going concern basis of accounting unless the Board of Directors

either intends to liquidate the Company or to cease operations, or has no realistic alternative

but to do so.

The Board of Directors is also responsible for overseeing the Company's financial reporting

process.

Auditor's Responsibilities for the Audit of the Financial Results

Our objectives are to obtain reasonable assurance about whether the Statement as a whole

are free from material misstatement, whether due to fraud or error, and to issue an auditor's

report that includes our opinion. Reasonable assurance is a high level of assurance but is not

a guarantee that an audit conducted in accordance with SAs will always detect a material

misstatement when it exists. Misstatements can arise from fraud or error and are considered

material if, individually or in the aggregate, they could reasonably be expected to influence

the economic decisions of users taken on the basis of the Statement.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain

professional skepticism throughout the audit. We also:

• Identify and assess the risks of material misstatement of the Statement, whether due to

fraud or error, design and perform audit procedures responsive to those risks, and obtain

audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk

of not detecting a material misstatement resulting from fraud is higher than for one

resulting from error, as fraud may involve collusion, forgery, intentional omissions,

misrepresentations, or the override of internal control.

• Obtain an understanding of internal control relevant to the audit in order to design audit

procedures that are appropriate in the circumstances. Under Section 143(3)(i) of the Act,

we are also responsible for expressing our opinion through a separate report on the

complete set of financial statements on whether the company has adequate internal

financial controls with reference to financial statements in place and the operating

effectiveness of such controls.

• Evaluate the appropriateness of accounting policies used and the reasonableness of

accounting estimates and related disclosures made by the Board of Directors.

• Conclude on the appropriateness of the Board of Directors' use of the going concern basis

of accounting and, based on the audit evidence obtained, whether a material uncertainty

exists related to events or conditions that may cast significant doubt on the Company's

ability to continue as a going concern. If we conclude that a material uncertainty eXists,

we are required to draw attention in our auditor's report to the related disclosures in the

financial results or, if such disclosures are inadequate, to modify our opinion. Our

conclusions are based on the audit evidence obtained up to the date of our auditor's report.

However, future events or conditions may cause the Company to cease to continue as a

going concern.

• Evaluate the overall presentation, structure and content of the financial results, including

the disclosures, and whether the Statement represent the underlying transactions and

events in a manner that achieves fair presentation.

We communicate with those charged with governance regarding, among other matters, the

planned scope and timing of the audit and significant audit findings, including any significant

deficiencies in internal control.th,!t we identify during our audit.

----------------Page (2) Break----------------

SHAH & SHAH ASSOCIATES

CHARTERED ACCOUNTANTS

702, ANIKET, Nr. MUNICIPAL MARKET,

e.G. ROAD, NAVRANGPURA, AHMEDABAD -380 009.

PHONE: 26465433 FAX: 079 -26406983

Email: ca@shahandshah.co.ln

We also provide those charged with governance with a statement that we have complied with

relevant ethical requirements regarding independence, and to communicate with them all

relationships and other matters that may reasonably be thought to bear on our independence,

and where applicable, related safeguards.

Other Matter:

The Statement includes the results for the quarter ended 31" March, 2025 and 31" March,

2024 being the balancing figure between audited figures in respect of the full financial year

ended 31" March, 2025 and 31" March, 2024 respectively and the published year to date

figures up to the third quarter of the respective financial years which were subjected to limited

review by us, as required under the Listing Regulations.

Our opinion is not qualified in respect of these matters.

Place

Date

Ahmedabad

May 30, 202S

For SHAH & SHAH ASSOCIATES

Chartered Accountants

Firm Regn. No. 113742W

I, t L' ______ __ 'l. C. ' ,,»

VASANT C. TANNA

Partner

Membership No. 100422

UDIN 2S100422BMIIVG4974

----------------Page (3) Break----------------

DENIS CHEM LAB LIMITED

MANUFACTURERS OF PARENTERAL PRODUCTS

[CIN: L24230GJ1980PLC003843]

ADDRESS: 401 – ABHISHREE, OPP. OM TOWER, SATELLITE ROAD, AHMEDABAD – 380 015 GUJARAT, INDIA TEL.: +91 (79) 26925716, 26925719 FAX: +91 (79) 26925710 Email:denischem401@gmail.com

REGD OFFICE & FACTORY: BLOCK NO. 457, VILLAGE: CHHATRAL, TAL: KALOL (N.G.) DIST: GANDHINAGAR – 382 729 GUJARAT,

TEL: +91 (2764) 233596, 233613 FAX: +91 (2764) 233896 WEB: www.denischemlab.com

A. FINANCIAL RESULTS:

STATEMENT OF STANDALONE AUDITED FINANCIAL RESULTS

FOR THE QUARTER & YEAR ENDED ON 31ST MARCH, 2025

(Rs. In lakh)

Particulars Quarter ended on Year ended on

(Refer Notes Below)

31-03-2025 31-12-2024 31-03-2024 31-03-2025 31-03-2024

(Audited)

(Refer notes)

(Unaudited)

(Audited)

(Refer notes) (Audited) (Audited)

1 Revenue from operations 4,138.34 4,284.13 3.985.49 17,329.97 16,782.20

2 Other income 117.22 30.00 59.46 237.45 138.77

3 Total Income (1+2) 4,255.56 4,314.13 4,044.95 17,567.42 16,920.97

4

Expenses

a. Cost of Materials consumed 1,968.60 2,159.14 1,919.21 8,643.69 8,004.63

b. Purchases of stock-in-trade 225.46 218.29 180.57 865.35 787.04

c. Changes in inventories of

finished goods, work-in-

progress and stock-in-trade

66.94 (23.72) (53.80) 67.64 (101.48)

d. Employee benefits expense 385.47 402.67 396.44 1,526.34 1,439.09

e. Finance costs 23.05 6.73 23.46 51.04 54.32

f. Depreciation & amortisation

expense 173.16 183.66 174.93 686.10 694.55

g. Other expenses 1,286.27 1,145.49 1,035.18 4,616.12 4,529.60

Total Expenses 4,128.95 4,092.27 3,675.99 16,456.28 15,407.75

5 Profit/ (Loss) before exceptional items and tax (3-4) 126.61 221.86 368.96 1,111.14 1,513.22

6 Exceptional items -

7 Profit / (Loss) before tax (5-6) 126.61 221.86 368.96 1,111.14 1,513.22

8 Tax expense:

Current tax 100.87 2.51 121.80 322.50 462.00

Deferred tax (45.01) 43.21 (25.76) (89.76) (88.98)

Short/(Excess) provision of

earlier years - - - 70.82 24.62

9

Profit/ (Loss) for the period

from continuing operations

(7-8)

70.75 176.14 272.92 807.58 1,115.58

10 Profit/ (loss) from discontinuing operations before Tax - - - - -

11 Tax expense of discontinuing operations - - - - -

12 Profit/ (loss) from Discontinuing operations (after tax) (10-11) - - - - -

13 Profit/ (Loss) for the period (9+12) 70.75 176.14 272.92 807.58 1,115.58

----------------Page (4) Break----------------

DENIS CHEM LAB LIMITED

MANUFACTURERS OF PARENTERAL PRODUCTS

[CIN: L24230GJ1980PLC003843]

ADDRESS: 401 – ABHISHREE, OPP. OM TOWER, SATELLITE ROAD, AHMEDABAD – 380 015 GUJARAT, INDIA TEL.: +91 (79) 26925716, 26925719 FAX: +91 (79) 26925710 Email:denischem401@gmail.com

REGD OFFICE & FACTORY: BLOCK NO. 457, VILLAGE: CHHATRAL, TAL: KALOL (N.G.) DIST: GANDHINAGAR – 382 729 GUJARAT,

TEL: +91 (2764) 233596, 233613 FAX: +91 (2764) 233896 WEB: www.denischemlab.com

Particulars Quarter ended on Year ended on

31-03-2025 31-12-2024 31-03-2024 31-03-2025 31-03-2024

(Audited)

(Refer notes)

(Unaudited)

(Audited)

(Refer notes)

(Audited) (Audited)

14 Other Comprehensive

Income

Items that will not be

reclassified subsequently to

profit or loss

Gain/(loss) on re-

measurement of defined

benefit plan

17.52 - (37.03) 17.52 (37.03)

Income tax relating to items

that will not be reclassified

to profit or loss

(4.41) - 9.32 (4.41) 9.32

Items that will be

reclassified subsequently to

profit or loss

- - - - -

Income tax relating to items

that will be reclassified to

profit or loss

- - - - -

Other Comprehensive

Income, net of tax

13.11 - (27.71) 13.11 (27.71)

15 Total Comprehensive

Income for the period

(13+14)

83.86 176.14 245.21 820.69 1,087.87

16 Paid-up equity shares capital

(Face Value per share Rs.

10/-)

1,387.67 1,387.67 1,387.67 1,387.67 1,387.67

17 Reserves excluding

Revaluation Reserves

7,122.75 6,648.98

18 Earnings Per Share of Rs.

10/- each (for continuing

operations)

Basic 0.51 1.27 1.97 5.82 8.04

Diluted 0.51 1.27 1.97 5.82 8.04

19 Earnings Per Share of Rs.

10/- each(for discontinued

operations)

Basic - - - - -

- Diluted - - - - -

20 Earnings Per Share of Rs.

10/- each(for discontinued &

continuing operations)

- Basic 0.51 1.27 1.97 5.82 8.04

- Diluted 0.51 1.27 1.97 5.82 8.04

----------------Page (5) Break----------------

DENIS CHEM LAB LIMITED

MANUFACTURERS OF PARENTERAL PRODUCTS

[CIN: L24230GJ1980PLC003843]

ADDRESS: 401 – ABHISHREE, OPP. OM TOWER, SATELLITE ROAD, AHMEDABAD – 380 015 GUJARAT, INDIA TEL.: +91 (79) 26925716, 26925719 FAX: +91 (79) 26925710 Email:denischem401@gmail.com

REGD OFFICE & FACTORY: BLOCK NO. 457, VILLAGE: CHHATRAL, TAL: KALOL (N.G.) DIST: GANDHINAGAR – 382 729 GUJARAT,

TEL: +91 (2764) 233596, 233613 FAX: +91 (2764) 233896 WEB: www.denischemlab.com

NOTES:

Sr. Particulars

1. These financial results were reviewed by the audit committee and thereafter have been

approved by the Board of Directors at their respective meetings held on May 30, 2025. The

Statutory Auditors have conducted audit of these financial results and issued an unmodified

opinion on the same.

2. These audited financial results have been prepared in accordance with the Indian Accounting

Standard (referred to as “IND AS”) prescribed under Section 133 of the Companies Act, 2013

read with Companies (Indian Accounting Standard) Rules as amended from time to time.

(Indian Accounting Standard) Rules as amended from time to time.

3. Figures for the quarter ended on 31st March, 2025 and 31st March, 2024, represents the

balancing figures between the audited figures for the full Financial Year ended on 31st March,

2025 and 31st March, 2024 and Unaudited year to date figures for the nine months upto 31st

December, 2024 and 31st December, 2023 respectively.

4. The Company is operating only in one segment i.e. manufacturing & sales of transfusion

solutions in bottles.

5. The Company does not have any subsidiary / associate.

6. The Indian Parliament has approved the Code on Social Security, 2020 which would impact

the contributions by the Company towards Provident Fund and Gratuity. The Ministry of

Labour and Employment has released draft rules for the Code on Social Security, 2020 on

November 13, 2020 and has invited suggestions from the stakeholders which are under active

consideration by the Ministry. The Company will assess the impact and its evaluation once the

subject rules are notified and will give appropriate impact in its financial statements in the

period in which, the said code become effective including related rules framed thereunder to

determine the financial impact are published.

7. During the quarter ended on 31st December,2024, the Company received an order together

with demand (including penalty) of Rs.12.09 crores from the office of the Commissioner

Central GST & Central Excise, Ahmedabad - Gandhinagar for the period commencing from

May 2000 to June 2017 in relation to classification of multiple products in the form of

“intravenous fluids” manufactured by the Company and cleared under the benefit of

exemption/concessional rate of duty. The Company has preferred an appeal before the

Customs, Excise and Service Tax Appellate Tribunal (CESTAT) and based on the facts and

merits of the case the management of the Company is confident about favorable outcome of

the same.

8. The Balance Sheet and Cash Flow Statement are attached as per Annexure-I and Annexure-II

respectively.

9. The figures for the corresponding previous year/period's have been regrouped/rearranged

wherever necessary.

10. The Board of Directors of the Company has recommended final dividend of Rs. 1.50 (@15%)

per Equity Share of Rs.10/- each for the financial year ended on 31st March, 2025, subject to

approval of shareholders at the ensuing Annual General Meeting.

Date : 30th May, 2025

Place : Ahmedabad

For DENIS CHEM LAB LIMITED

HIMANSHU C. PATEL

MANAGING DIRECTOR

DIN: 00087114

----------------Page (6) Break----------------

DENIS CHEM LAB LIMITED

MANUFACTURERS OF PARENTERAL PRODUCTS

[CIN: L24230GJ1980PLC003843]

ADDRESS: 401 – ABHISHREE, OPP. OM TOWER, SATELLITE ROAD, AHMEDABAD – 380 015 GUJARAT, INDIA TEL.: +91 (79) 26925716, 26925719 FAX: +91 (79) 26925710 Email:denischem401@gmail.com

REGD OFFICE & FACTORY: BLOCK NO. 457, VILLAGE: CHHATRAL, TAL: KALOL (N.G.) DIST: GANDHINAGAR – 382 729 GUJARAT,

TEL: +91 (2764) 233596, 233613 FAX: +91 (2764) 233896 WEB: www.denischemlab.com

Annexure-I

STATEMENT OF ASSETS AND LIABILITIES:

(Rs. In lakh)

Sr. No. Particulars As at 31-03-2025 As at 31-03-2024

ASSETS

1 Non-Current Assets

Property, plant and equipment 3,871.80 3,744.18

Capital work-in-progress 7.18 22.36

Investment property - -

Goodwill - -

Other intangible Assets 10.70 17.81

Intangible Assets under development - -

Investments accounted for using equity method - -

Biological Assets other than bearer plants - -

Non-Current Financial Assets: - -

(i) Investments, Non-Current - -

(ii) Trade receivables, Non-Current - -

(iii) Loans, Non-Current - -

(iv) Other non current financial asset 216.14 127.02

Income Tax Asset 17.51 18.28

Deferred tax Assets (net) - -

Other Non-Current Assets 39.44 68.02

Total Non-Current Assets 4,162.76 3,997.67

2 Current Assets

Inventories 980.88 1,018.97

Current financial asset:

(i) Current investments - -

(ii) Trade receivables, Current 3,061.48 3,165.89

(iii) Cash and cash equivalents 85.03 119.33

(iv) Bank balance other than above 2,538.34 2,395.64

(v) Loans, Current - -

(vi) Other Current financial Assets 164.33 64.58

Current tax Assets (net) - -

Other Current Assets 234.41 172.79

Total Current Assets 7,064.47 6,937.20

TOTAL ASSETS 11,227.24 10,934.87

----------------Page (7) Break----------------

DENIS CHEM LAB LIMITED

MANUFACTURERS OF PARENTERAL PRODUCTS

[CIN: L24230GJ1980PLC003843]

ADDRESS: 401 – ABHISHREE, OPP. OM TOWER, SATELLITE ROAD, AHMEDABAD – 380 015 GUJARAT, INDIA TEL.: +91 (79) 26925716, 26925719 FAX: +91 (79) 26925710 Email:denischem401@gmail.com

REGD OFFICE & FACTORY: BLOCK NO. 457, VILLAGE: CHHATRAL, TAL: KALOL (N.G.) DIST: GANDHINAGAR – 382 729 GUJARAT,

TEL: +91 (2764) 233596, 233613 FAX: +91 (2764) 233896 WEB: www.denischemlab.com

(Rs. In lakh)

Sr.

No.

Particulars As at 31-03-2025 As at 31-03-2024

EQUITY AND LIABILITIES

1 Equity

Equity share capital 1,387.67 1,387.67

Other Equity 7,122.75 6,648.98

Total Equity 8,510.42 8,036.65

2 Liabilities

Non-Current Liabilities

Non-Current financial Liabilities:

(i) Borrowings, Non-Current 45.31 45.17

(ii) Trade payables, Non-Current - -

(a) total outstanding dues of micro

enterprises and small enterprises

- -

(b) total outstanding dues of creditors

other than micro enterprises and small

enterprises

- -

(iii) Other Non-Current financial Liabilities 43.45 37.34

Provisions, Non-Current 10.81 96.16

Deferred tax Liabilities (net) - -

Deferred government grants, non current - -

Other Non-Current Liabilities - -

Total Non-Current Liabilities 99.57 178.67

Current Liabilities

Current financial Liabilities:

(i) Borrowings, Current 36.73 59.43

(ii) Trade payables, Current

(a) total outstanding dues of micro enterprises and

small enterprises 340.91 -

(b) total outstanding dues of creditors other than

micro enterprises and small enterprises

1,782.85 2,140.83

(iii) Other Current financial Liabilities 334.51 292.87

Other Current Liabilities 77.06 40.24

Provisions, Current 5.78 50.61

Current tax Liabilities (Net) 39.41 135.57

Deferred government grants, current - -

Total Current Liabilities 2,617.25 2,719.55

Total Liabilities 2,716.82 2,898.22

TOTAL EQUITY AND LIABILITIES 11,227.24 10,934.87

----------------Page (8) Break----------------

DENIS CHEM LAB LIMITED

MANUFACTURERS OF PARENTERAL PRODUCTS

[CIN: L24230GJ1980PLC003843]

ADDRESS: 401 – ABHISHREE, OPP. OM TOWER, SATELLITE ROAD, AHMEDABAD – 380 015 GUJARAT, INDIA TEL.: +91 (79) 26925716, 26925719 FAX: +91 (79) 26925710 Email:denischem401@gmail.com

REGD OFFICE & FACTORY: BLOCK NO. 457, VILLAGE: CHHATRAL, TAL: KALOL (N.G.) DIST: GANDHINAGAR – 382 729 GUJARAT,

TEL: +91 (2764) 233596, 233613 FAX: +91 (2764) 233896 WEB: www.denischemlab.com

Annexure-II

STATEMENT OF CASH FLOW FOR THE YEAR ENDED 31ST MARCH, 2025

(Rs. In lakh)

Particulars

For the year

ended

31st March, 2025

For the year

ended

31st March, 2024

(A) Cash flow from operating activities

Profit before tax 1,111.14 1,513.22

Adjustment for:

Finance Costs 51.04 54.32

Depreciation and amortisation 686.10 694.55

Interest received (183.83) (127.50)

profit On sale of Assets (Net) - -

Reversal of Provision for Expected Credit Loss (ECL) 17.52 (37.03)

Unrealised foreign exchange fluctuation (gain)/loss - -

Remeasurement of defined benefit obligations - -

Operating Profit / (Loss) before working capital changes 1,681.97 2,097.57

Changes in working capital:

(Increase)/Decrease in Inventories 38.09 (106.59)

(Increase)/Decrease in Trade Receivables 104.41 (41.83)

(Increase)/Decrease in Other Financial Assets (87.64) 24.83

(Increase)/Decrease in Other Assets (61.62) (69.11)

Increase/(Decrease) in Trade Payables (17.07) 312.69

Increase/(Decrease) in Provisions (38.73) 60.43

Increase / (Decrease) in Other Current Liabilities 36.83 (27.13)

Increase / (Decrease) in Other Liabilities 41.64 (35.20)

Cash generated / (used in) from operations 1,697.88 2,215.65

Less : Tax Paid (net of refunds, if any) (488.69) (434.19)

Net Cash generated from operating activities (A) 1,209.19 1,781.47

(B) Cash flow from investing activities

Capital expenditure on Property, Plant and Equipment, Intangible assets,

Capital Work in progress (762.84) (692.78)

Insurance claim received for fixed assets - -

Interest received 82.58 106.38

Bank deposits / margin money withdrawn / (placed) (net) (142.71) (903.05)

Net Cash used in investing activities (B) (822.97) (1,489.45)

----------------Page (9) Break----------------

DENIS CHEM LAB LIMITED

MANUFACTURERS OF PARENTERAL PRODUCTS

[CIN: L24230GJ1980PLC003843]

ADDRESS: 401 – ABHISHREE, OPP. OM TOWER, SATELLITE ROAD, AHMEDABAD – 380 015 GUJARAT, INDIA TEL.: +91 (79) 26925716, 26925719 FAX: +91 (79) 26925710 Email:denischem401@gmail.com

REGD OFFICE & FACTORY: BLOCK NO. 457, VILLAGE: CHHATRAL, TAL: KALOL (N.G.) DIST: GANDHINAGAR – 382 729 GUJARAT,

TEL: +91 (2764) 233596, 233613 FAX: +91 (2764) 233896 WEB: www.denischemlab.com

(Rs. In lakh)

Particulars

For the year

ended

31st March, 2025

For the year

ended

31st March, 2024

(C) Cash flow from financing activities

Dividend and dividend tax paid (346.92) (277.53)

Increase/(Decrease) in Short-term borrowings (22.70) (41.86)

Increase/(Decrease) in Long-term borrowings 0.14 (46.90)

Finance Costs Paid (51.04) (54.32)

Unrealised foreign exchange fluctuation (gain)/loss -

Net Cash generated from financing activities (C) (420.52) (420.62)

Net Increase / (Decrease) in cash and cash equivalents (A)+(B)+(C) (34.30) (128.60)

Cash and cash equivalents at the beginning of the year 119.33 247.93

Cash and cash equivalents at the end of the year 85.03 119.33

Notes to Cash flow Statement :

Cash and cash equivalents as per above comprise of the following :

Cash and cash equivalents 85.03 119.33

Balances as per statement of cash flows 85.03 119.33

Date : 30th May, 2025

Place : Ahmedabad

For DENIS CHEM LAB LIMITED

HIMANSHU C. PATEL

MANAGING DIRECTOR

DIN: 00087114

----------------Page (10) Break----------------

DENIS CHEM LAB LIMITED

MANUFACTURERS OF PARENTERAL PRODUCTS

[CIN: L24230GJ1980PLC003843]

ADDRESS: 401 – ABHISHREE, OPP. OM TOWER, SATELLITE ROAD, AHMEDABAD – 380 015 GUJARAT, INDIA TEL.: +91 (79) 26925716, 26925719 FAX: +91 (79) 26925710 Email:denischem401@gmail.com

REGD OFFICE & FACTORY: BLOCK NO. 457, VILLAGE: CHHATRAL, TAL: KALOL (N.G.) DIST: GANDHINAGAR – 382 729 GUJARAT,

TEL: +91 (2764) 233596, 233613 FAX: +91 (2764) 233896 WEB: www.denischemlab.com

B. STATEMENT ON DEVIATION OR VARIATION FOR PROCEEDS OF PUBLIC ISSUE,

RIGHTS ISSUE, PREFERENTIAL ISSUE, QUALIFIED INSTITUTIONS PLACEMENT

ETC.

: Not Applicable

C. FORMAT FOR DISCLOSING OUTSTANDING DEFAULT ON LOANS AND DEBT

SECURITIES:

: Not Applicable

Sr. No. Particulars in INR crore

1. Loans / revolving facilities like cash credit from banks / financial institutions

A. Total amount outstanding as on date 0

B. Of the total amount outstanding, amount of default as on

date

0

2. Unlisted debt securities i.e. NCDs and NCRPS

A. Total amount outstanding as on date 0

B. Of the total amount outstanding, amount of default as on

date

0

3. Total financial indebtedness of the listed entity including

short-term and long-term debt

0

D. DISCLOSURE OF RELATED PARTY TRANSACTIONS FOR HALF YEAR ENDED 31ST

MARCH, 2025:

As per Annexure - III

E. STATEMENT ON IMPACT OF AUDIT QUALIFICATIONS (FOR AUDIT REPORT WITH

MODIFIED OPINION) SUBMITTED ALONG-WITH ANNUAL AUDITED FINANCIAL

RESULTS (Standalone and Consolidated separately) (applicable only for Annual Filing i.e., 4th

quarter)

: Not Applicable

Date : 30th May, 2025

Place : Ahmedabad

For DENIS CHEM LAB LIMITED

HIMANSHU C. PATEL

MANAGING DIRECTOR

DIN: 00087114

----------------Page (11) Break----------------

DENIS CHEM LAB LIMITED

MANUFACTURERS OF PARENTERAL PRODUCTS

[CIN: L24230GJ1980PLC003843]

ADDRESS: 401 – ABHISHREE, OPP. OM TOWER, SATELLITE ROAD, AHMEDABAD – 380 015 GUJARAT, INDIA TEL.: +91 (79) 26925716, 26925719 FAX: +91 (79) 26925710 Email:denischem401@gmail.com

REGD OFFICE & FACTORY: BLOCK NO. 457, VILLAGE: CHHATRAL, TAL: KALOL (N.G.) DIST: GANDHINAGAR – 382 729 GUJARAT,

TEL: +91 (2764) 233596, 233613 FAX: +91 (2764) 233896 WEB: www.denischemlab.com

30th May, 2025

BSE Limited

PhirozeJeejeebhoy Towers,

Dalal Street, Fort,

Mumbai - 400 001

Company Code No. 537536

Dear Sir,

Sub: Declaration regarding Audit report with unmodified opinion with respect to Annual Audited

Financial Results for the Financial Year ended 31st March, 2025

Pursuant to Regulation 33(3) (d) of SEBI (Listing Obligations and Disclosures Requirements)

Regulations, 2015, and SEBI Circular No.CIR/CFD/CMD/56/2016 dated 27th May, 2016, it is hereby

declared and confirmed that Auditors’ Report obtained from the Statutory Auditors, M/s. Shah & Shah

Associates, Chartered Accountants on Annual Audited Financial Results of the Company for the financial

year ended 31st March, 2025 has an unmodified opinion.

Kindly take the above information on record.

Thanking you,

Yours faithfully,

for DENIS CHEM LAB LIMITED

HIMANSHU C. PATEL

MANAGING DIRECTOR

(DIN: 00087114)

----------------Page (12) Break----------------

Amount in (Lakhs)

NamePANNamePANRelationship of the counterparty with the listed entity or its subsidiaryOpening balance Closing balanceNature of indebtedness (loan/ issuance of debt/ any other etc.)Details of other indebtednessCostTenureNature (loan/ advance/ intercorporate deposit/ investment)Interest Rate (%)TenureSecured/ unsecuredPurpose for which the funds will be utilised by the ultimate recipient of funds (endusage)Notes

1DENIS CHEM LAB LIMITEDHIMANSHU C PATELEmployer - EmployeeRemunerationApproved69.690.000.002DENIS CHEM LAB LIMITEDNIRMAL H PATELEmployer - EmployeeRemunerationApproved38.400.000.003DENIS CHEM LAB LIMITEDVIKRAM JOSHIEmployer - EmployeeRemunerationApproved22.730.000.00

4DENIS CHEM LAB LIMITEDANAL R DESAIEmployer - EmployeeRemunerationApproved2.410.000.005DENIS CHEM LAB LIMITEDANAR HIMANSHU PATELDirectorAny other transactionDirector Sitteing FeesApproved0.040.000.006DENIS CHEM LAB LIMITEDHEMANG PATELDirectorAny other transactionDirector Sitteing FeesApproved0.040.000.00

7DENIS CHEM LAB LIMITEDHEMENDRA SHAHDirectorAny other transactionDirector Sitteing FeesApproved0.040.000.008DENIS CHEM LAB LIMITEDDIPAK N PATELDirectorAny other transactionDirector Sitteing FeesApproved0.040.000.009DENIS CHEM LAB LIMITEDDINESHBHAIDirectorAny other transactionDirector Sitteing FeesApproved0.040.000.00

10DENIS CHEM LAB LIMITEDANAR HIMANSHU PATELServiceSale of goods or servicesApproved21.383.243.5611DENIS CHEM LAB LIMITEDANAR HIMANSHU PATELDeposit- ReceivedLoanApproved42.3345.1845.3112DENIS CHEM LAB LIMITEDANAR HIMANSHU PATELDeposit- PaymentLoanApproved42.1945.1845.31

13 DENIS CHEM LAB LIMITEDDENIS PACKAGING (HIMANSHU C PATEL -HUF)JOB-WORKPurchase of goods or servicesApproved70.4067.1351.26Total value of transaction during the reporting period309.73

Notes:

Details of the loans, inter-corporate deposits, advances or investmentsDate of Audit Committee Meeting

where the ratification was approved

1. The details in this format are required to be provided for all transactions undertaken during the reporting period. However, opening and closing balances, including commitments, to be disclosed for existing related party transactions even if there is no new related party transaction during the reporting period.2. Where a transaction is undertaken between members of the consolidated entity (between the listed entity and its subsidiary or between subsidiaries), it may be reported once.

3. Listed banks shall not be required to provide the disclosures with respect to related party transactions involving loans, inter-corporate deposits, advances or investments made or given by the listed banks.4. For companies with financial year ending March 31, this information has to be provided for six months ended September 30 and six months ended March 31. Companies with financial years ending in other months, the six months period shall apply accordingly.

5. Each type of related party transaction (for e.g. sale of goods/services, purchase of goods/services or whether it involves a loan, inter-corporate deposit, advance or investment) with a single party shall be disclosed separately and there should be no clubbing or netting of transactions of same type. However, transactions with the same counterparty of the same type may be aggregated for the reporting period. For instance, sale transactions with the same party may be aggregated for the reporting period and purchase transactions may also be disclosed in a similar

manner. There should be no netting off for sale and purchase transactions. Similarly, loans advanced to and received from the same counterparty should be disclosed separately, without any netting off.6. In case of a multi-year related party transaction: a. The aggregate value of such related party transaction as approved by the audit committee shall be disclosed in the column “Value of the related party transaction as approved by the audit committee”.

b. The value of the related party transaction ratified by the audit committee shall be disclosed in the column “Value of the related party transaction ratified by the audit committee”. c. The value of the related party transaction undertaken in the reporting period shall be reported in the column “Value of related party transaction during the reporting period”.7. "Cost" refers to the cost of borrowed funds for the listed entity. 8. Transactions such as acceptance of fixed deposits by banks/NBFCs, undertaken with related parties, at the terms uniformly applicable /offered to all shareholders/ public shall also be reported.

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was

undertaken.

Sr. No.

Details of the party (listed entity /subsidiary) entering into the transactionDetails of the counterparty

Type of related party transactionDetails of other related party transactionValue of the related party transaction as approved by the audit committeeRemarks on approval by audit committeeValue of the related party transaction ratified by the audit committeeValue of transaction during the reporting period

In case monies are due to either party as a result of the transactionIn case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments

HomeValidate

DeleteAdd

Annexure- III

----------------Page (13) Break----------------